Mucolytic expectorant to clear and maintain airways.

Composition
Contains: Ambroxol hydrochloride 6 mg/mL

Features and Benefits
AMBROXOL is a mucolytic expectorant. Ambroxol is an active metabolite of bromhexine, and acts to reduce the viscosity of tenacious mucus secretions by fragmentation of long mucopolysaccharide chains, resulting in a productive cough which aids expectoration of liquefied mucoid respiratory secretions, and assists in clearing and maintaining patent bronchioles and alveoli, hence reducing dyspnoea.
AMBROXOL enhances the concentrations of chemotherapeutic agents in bronchial secretions to result in a more rapid recovery.

Indications
AMBROXOL is indicated to aid in the treatment of catarrhal inflammation of bronchi and the upper respiratory tract in horses and dogs. Specific indications include:
Chest Infections: acute and chronic bronchopneumonia, catarrhal rhinitis, strangles, post-viral cough
Uterine Infections: pyometron, mucometron
Ocular Infections: purulent conjunctivitis, hypopion.

Dosage and Administration
Horse: 0.3 mg/kg (5 mL/100 kg) bodyweight by intravenous injection twice daily.
Dogs: 0.6 mg/kg (1mL/10 kg) bodyweight by intravenous injection twice daily.
Administer AMBROXOL by intravenous injection.
It is safe to use AMBROXOL for extended periods.

Warnings
Meat Withholding Period : Horses - 28 days.

Presentation
100 mL sterile multi-dose glass vial.

Storage
Store below 25^˚C (air conditioning). Protect from light.

Poisons Schedule
S4

APVMA Approval Number
51134